Congress

First Opinion

Grassley: For Medicaid, greater transparency will open the door to better value and outcomes

By Chuck Grassley

Politics

‘Don’t be a Bernie Bro’: Inside conservatives’ brazen campaign to sabotage Trump’s signature drug pricing plan

By Lev Facher

Politics

Grassley to pharma: Support my drug pricing bill, or get ready to roll the dice with Trump

By Nicholas Florko

Politics

Key Senate committee advances its sweeping drug pricing bill — and keeps caps on price hikes

By Lev Facher and Nicholas Florko

Politics

With a flood of amendments, some senators seek to water down drug-pricing bill

By Nicholas Florko

Politics

6 burning questions about the Senate Finance Committee’s ambitious new drug pricing plan

By Nicholas Florko

Pharmalot

Pharmalittle: New records show drug makers’ opioid push; Senate bill would cap Medicare drug price hikes

By Ed Silverman

Politics

Senate committee unveils ambitious plan to cap drug price hikes, out-of-pocket expenses

By Lev Facher and Nicholas Florko

Politics

Former pharma hawk McCaskill: Drug pricing system is a ‘stinking stew of a mess’

By Lev Facher

Politics

PhRMA scrambles to fight potential drug pricing reforms in budget deal

By Nicholas Florko

Politics

Pharma deploys its top guns to Capitol Hill as senators mull drug pricing package

By Lev Facher, Nicholas Florko, and Andrew Joseph

Politics

Tracking Washington’s moves on drug pricing

By Nicholas Florko and Lev Facher

D.C. Diagnosis

How the drug industry keeps winning in Washington

By Nicholas Florko

Pharmalot

Pharmalittle: Pharma keeps winning in Washington; J&J faces test as Oklahoma opioid trial wraps up

By Ed Silverman

Politics

Kamala Harris becomes the latest Democratic candidate to zero in on drug prices

By Lev Facher

Special Report

How pharma, under attack from all sides, keeps winning in Washington

By Nicholas Florko and Lev Facher

Politics

Following ‘CRISPR babies’ scandal, senators call for international gene editing guidelines

By Andrew Joseph

Pharmalot

Lawmakers urge Trump administration to alter trade deal or Americans will pay more for drugs

By Ed Silverman

First Opinion

Newborn screening saves lives. Congress needs to reauthorize the program

By R. Rodney Howell

Politics

After Trump pulled the plug on rebates, his options to reduce drug prices narrow. And he may need Congress

By Andrew Joseph and Damian Garde

Pharmalot

Pharmalittle: White House edges near drug deal with Capitol Hill; U.K. offers plan for antibiotic development

By Ed Silverman

Politics

Top Trump advisers hint at support for progressive proposal to cap drug price hikes

By Lev Facher and Nicholas Florko

D.C. Diagnosis

So much for Trump’s rule about drug prices in TV ads

By Nicholas Florko

D.C. Diagnosis

Digging into the FDA’s grievance hotline

By Nicholas Florko

Politics

Elizabeth Warren blasts former FDA commissioner for joining Pfizer’s board

By Lev Facher

AIDS activists say Gilead put profits over patients — and misled Congress about an HIV pill

Despite their pledges, Democrats haven’t yet lowered drug prices. Here’s how they’re explaining themselves

Sanders and Cummings renew probe into generic pricing they say was ‘stonewalled’

As Bernie Sanders neared, Canadian officials were urged not to allow U.S. to import medicines

Grassley: For Medicaid, greater transparency will open the door to better value and outcomes

‘Don’t be a Bernie Bro’: Inside conservatives’ brazen campaign to sabotage Trump’s signature drug pricing plan

Grassley to pharma: Support my drug pricing bill, or get ready to roll the dice with Trump

Key Senate committee advances its sweeping drug pricing bill — and keeps caps on price hikes

With a flood of amendments, some senators seek to water down drug-pricing bill

6 burning questions about the Senate Finance Committee’s ambitious new drug pricing plan

Pharmalittle: New records show drug makers’ opioid push; Senate bill would cap Medicare drug price hikes

Senate committee unveils ambitious plan to cap drug price hikes, out-of-pocket expenses

Former pharma hawk McCaskill: Drug pricing system is a ‘stinking stew of a mess’

PhRMA scrambles to fight potential drug pricing reforms in budget deal

Pharma deploys its top guns to Capitol Hill as senators mull drug pricing package

Tracking Washington’s moves on drug pricing

How the drug industry keeps winning in Washington

Pharmalittle: Pharma keeps winning in Washington; J&J faces test as Oklahoma opioid trial wraps up

Kamala Harris becomes the latest Democratic candidate to zero in on drug prices

How pharma, under attack from all sides, keeps winning in Washington

Following ‘CRISPR babies’ scandal, senators call for international gene editing guidelines

Lawmakers urge Trump administration to alter trade deal or Americans will pay more for drugs

Newborn screening saves lives. Congress needs to reauthorize the program

After Trump pulled the plug on rebates, his options to reduce drug prices narrow. And he may need Congress

Pharmalittle: White House edges near drug deal with Capitol Hill; U.K. offers plan for antibiotic development

Top Trump advisers hint at support for progressive proposal to cap drug price hikes

So much for Trump’s rule about drug prices in TV ads

Digging into the FDA’s grievance hotline

Elizabeth Warren blasts former FDA commissioner for joining Pfizer’s board